1. Home
  2. CLRB vs FBGL Comparison

CLRB vs FBGL Comparison

Compare CLRB & FBGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLRB
  • FBGL
  • Stock Information
  • Founded
  • CLRB 2002
  • FBGL 1996
  • Country
  • CLRB United States
  • FBGL Singapore
  • Employees
  • CLRB N/A
  • FBGL N/A
  • Industry
  • CLRB Biotechnology: Pharmaceutical Preparations
  • FBGL Miscellaneous manufacturing industries
  • Sector
  • CLRB Health Care
  • FBGL Consumer Discretionary
  • Exchange
  • CLRB Nasdaq
  • FBGL Nasdaq
  • Market Cap
  • CLRB 12.8M
  • FBGL 10.5M
  • IPO Year
  • CLRB N/A
  • FBGL 2025
  • Fundamental
  • Price
  • CLRB $3.36
  • FBGL $0.56
  • Analyst Decision
  • CLRB Hold
  • FBGL
  • Analyst Count
  • CLRB 2
  • FBGL 0
  • Target Price
  • CLRB N/A
  • FBGL N/A
  • AVG Volume (30 Days)
  • CLRB 321.2K
  • FBGL 265.3K
  • Earning Date
  • CLRB 10-31-2025
  • FBGL 11-23-2025
  • Dividend Yield
  • CLRB N/A
  • FBGL N/A
  • EPS Growth
  • CLRB N/A
  • FBGL N/A
  • EPS
  • CLRB N/A
  • FBGL N/A
  • Revenue
  • CLRB N/A
  • FBGL $10,491,303.00
  • Revenue This Year
  • CLRB N/A
  • FBGL N/A
  • Revenue Next Year
  • CLRB N/A
  • FBGL N/A
  • P/E Ratio
  • CLRB N/A
  • FBGL N/A
  • Revenue Growth
  • CLRB N/A
  • FBGL N/A
  • 52 Week Low
  • CLRB $3.17
  • FBGL $0.41
  • 52 Week High
  • CLRB $66.00
  • FBGL $5.45
  • Technical
  • Relative Strength Index (RSI)
  • CLRB 32.40
  • FBGL 43.79
  • Support Level
  • CLRB $3.70
  • FBGL $0.55
  • Resistance Level
  • CLRB $4.10
  • FBGL $0.65
  • Average True Range (ATR)
  • CLRB 0.32
  • FBGL 0.08
  • MACD
  • CLRB -0.08
  • FBGL 0.00
  • Stochastic Oscillator
  • CLRB 9.69
  • FBGL 52.30

About CLRB Cellectar Biosciences Inc.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

About FBGL FBS Global Limited Ordinary Shares

FBS Global Ltd is a green building contractor and an established interior fit-out specialist in institutional, residential, commercial, and industrial building projects. As a green contractor focused on environmentally sound practices, the company aims to bid tenders for green building projects, use green construction methods and green materials for construction projects, including design, supply and installation of ceilings, partitions, timber deck, carpet, acoustic wall paneling, built-in furniture as well as mechanical and electrical services of a building. The company's revenue is derived mainly from the construction contracts and Sales of construction materials.

Share on Social Networks: